Dr. Taylor Ripley has joined the Division of Thoracic Surgery at Baylor St. Luke’s Medical Center to serve as the Director of the Mesothelioma Treatment Center. He was recruited by Dr. David Sugarbaker, the former Director of Thoracic Surgery. Dr. Ripley was specifically chosen to continue the work Dr. Sugarbaker had started at Baylor before his sudden passing at the end of August 2018.
Dr. Ripley brings a great deal of experience to the table with a long history of treating mesothelioma. He also specializes in robotic thoracic surgery and surgical oncology. According to Dr. Kent Osborne, director of the NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor,
“The Lung Institute and Dan L Duncan Comprehensive Cancer Center at Baylor are Centers of Excellence for diagnosis and treatment of mesothelioma. Dr. Taylor Ripley’s recruitment will add to and expand our expertise, thereby assuring that our patients receive unparalleled care.”
His addition to the Dan L Duncan Comprehensive Cancer Center will bring a new dimension of treatment capabilities to the hospital’s already world-class staff and facilities.
Ripley completed a fellowship in thoracic surgery at Memorial Sloan Kettering where he first became familiar with mesothelioma cancer. For the last four years, Dr. Ripley worked with some of the top mesothelioma specialists including Dr. Raffit Hassan at the National Cancer Institute before joining the team at Baylor.
One of his main goals as the Director of the Mesothelioma Center is to further the laboratory research conducted at Baylor to develop new clinical trials that might one day become better standard treatments for this rare and aggressive cancer. His experience with robotic surgery is also of particular interest.
The development of robotic thoracic surgery in the treatment of mesothelioma is gaining a great deal of traction in recent years. Now, surgeons can conduct intricate procedures with the help of delicate robotic instruments, allowing them to resect cancerous tissue with greater precision. The addition of this experience to the multidisciplinary program at Baylor will be invaluable to the patients seeking treatment at this world-renowned center.
Dr. Ripley stated, in a press release published by Baylor on the announcement of his hiring as Director, that:
“I see an exciting opportunity to contribute to the multidisciplinary approach to patients with mesothelioma as well as all thoracic cancers at Baylor and Baylor St. Luke’s Medical Center, and I look forward to working with teams from across the Lung Institute, Dan L Duncan Cancer Comprehensive Center and Department of Surgery to offer more services to our patients.”
His addition to the staff at Baylor St. Luke’s Medical Center will be a huge asset to the hospital, and his previous experience with treating mesothelioma and other forms of cancer are likely to aid in the continued research and eventual development of new, more effective treatments.